Lysophosphatidylcholine posttranscriptionally inhibits interferon-γ- induced IP-10, Mig and I-Tac expression in endothelial cells

Cardiovascular Research

Volumn 65, Issue 1, 2005, Pages 263-271

  Md Sheikh, Abdullah ^a   Ochi, Hiroshi ^a   Manabe, Atsushi ^a   Masuda, Junichi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Endothelial cells; Interferon ; IP_10; Lysophosphatidylcholine; mRNA stability

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANIDINE BINDING PROTEIN 1; INTERFERON REGULATORY FACTOR 1; LYSOPHOSPHATIDYLCHOLINE; PROTEIN; PROTEIN P48; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONCENTRATION RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ARTERIOSCLEROSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINES; CHEMOKINES, CXC; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE II; LYSOPHOSPHATIDYLCHOLINES; PYRIMIDINONES; THIAZOLES;

EID: 11144330115     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.09.017     Document Type: Article

References (42)

1. J.L. Witztum, and D. Steinberg Role of oxidized low-density lipoprotein in atherogenesis J. Clin. Invest. 88 1991 1785 1792
2. U.P. Steinbrecher, S. Parthasarathy, D.S. Leake, J.L. Witzum, and D. Steinberg Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids Proc. Natl. Acad. Sci. U. S. A. 81 1984 3883 3887
3. O.W. Portman, and M. Alexander Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis J. Lipid Res. 10 1969 158 165
4. N. Kume, and M.A. Gimbrone Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured endothelial cell J. Clin. Invest. 93 1994 907 911
5. M. Morimoto, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, and M. Minami Lysophosphatidylcholine induces early growth response factor-1 expression and activates the core promoter of PDGF-A chain in vascular endothelial cells Arterioscler. Thromb. Vasc. Biol. 21 2001 771 776
6. N. Kume, M.I. Cybulsky, and M.A. Gimbrone Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells J. Clin. Invest. 90 1992 1138 1144
7. H. Ochi, N. Kume, E. Nishi, and T. Kita Elevated level of cAMP inhibit protein kinase C independent mechanisms of endothelial platelet-derived growth factor-B chain and intercellular adhesion molecule-1 gene induction by lysophosphatidylcholine Circ. Res. 77 1995 530 535
8. K. Cieslik, A. Zembowicz, J.L. Tang, and K.K. Wu Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine J. Biol. Chem. 24 1998 14885 14890
9. H. Oka, K. Kugiyama, H. Doi, T. Matsumura, H. Shibata, and L.A. Miles Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway Arterioscler. Thromb. Vasc. Biol. 20 2000 244 250
10. E. Nishi, N. Kume, Y. Ueno, H. Ochi, H. Moriwaki, and T. Kita Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocyte Circ. Res. 83 1998 508 515
11. M.T. Quinn, S. Parthasarathy, and D. Steinberg Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis Proc. Natl. Acad. Sci. U. S. A. 85 1988 2805 2809
12. C.G. Radu, L.V. Yang, M. Reidinger, M. Au, and O.N. Witte T cell chemotaxis to lysophosphatidylcholine through G2A receptor Proc. Natl. Acad. Sci. U. S. A. 101 2004 245 250
13. S. Sakata-Kaneko, T. Wakatsuki, T. Usui, Y. Matsunaga, T. Itoh, and E. Nishi Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+T cells FEBS Lett. 433 1998 161 165
14. K. Lauber, E. Bohn, S.M. Krober, Y.J. Xiao, S.G. Blumenthal, and R.K. Lindemann Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal Cell 113 2003 717 730
15. T. Aprahamian, I. Rifkin, R. Bonegio, B. Hugel, J.M. Freyssinet, and K. Sato Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease J. Exp. Med. 199 2004 1121 1131
16. L.Q. Le, J.H.S. Kabarowski, Z. Weng, A.B. Satterthwaite, E.T. Harvill, and E.R. Jensen Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome Immunity 14 2001 561 571
17. B. Lechleitner, J. Gille, D.R. Johnson, and P. Petzelbauer Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway J. Exp. Med. 187 1998 2023 2030
18. M.J. Yellin, J. Brett, D. Baum, A. Matsushima, M. Szabolcs, and D. Stern Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals J. Exp. Med. 182 1995 1857 1864
19. F. Mach, A. Sauty, A.S. Iarossi, G.K. Sukhova, K. Neote, and P. Libby Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells J. Clin. Invest. 104 1999 1041 1050
20. M. Loetscher, B. Gerber, P. Loetscher, S.A. Jones, L. Piali, and I. Clark-Lewis Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes J. Exp. Med. 184 1996 963 969
21. K.E. Cole, C.A. Strick, T.J. Paradis, K.T. Ogbone, M. Loetscher, and R.P. Glaude Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 J. Exp. Med. 187 1998 2009 2021
22. S. Gupta, A.M. Pablo, X.C. Jiang, N. Wang, A.R. Tall, and C. Schinder IFNγ potentiates atherosclerosis in apoE knock-out mice J. Clin. Invest. 99 1997 2752 2761
23. S.C. Whitman, P. Ravisankar, H. Elam, and A. Daupherty Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/-mice Am. J. Pathol. 157 2000 1819 1824
24. C.V. Ramana, M.P. Gil, R.D. Schreiber, and G.R. Stark Stat 1-dependent and -independent pathways in IFN-γ-dependent signaling Trends Immunol. 23 2002 96 101
25. S. Majumder, L.Z.H. Zhou, P. Chaturvedi, G. Babcock, S. Aras, and R.M. Ransohoff p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10kDa (IP-10) by IFN-γ alone or in synergy with TNF-α J. Immunol. 161 1998 4736 4744
26. M.R.S. Rani, G.R. Foster, S. Leung, D. Leaman, G.R. Stark, and R.M. Ransohoff Characterization of β-R1, a gene that is selectively induced by interferon β(IFN-β) compared with IFN-α J. Biol. Chem. 271 1996 22878 22884
27. V. Briken, H. Ruffner, U. Schultz, A. Schwarz, L.F.L. Reis, and I. Strelow Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon Mol. Cell Biol. 15 1995 975 982
28. H. Ochi, J. Masuda, and M.A. Gimbrone Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity Eur. J. Immunol. 32 2002 1821 1831
29. T. Murase, N. Kume, R. Korenaga, J. Ando, T. Sawamura, and T. Masaki Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells Circ. Res. 83 1998 328 333
30. Y. Ohmori, and T.A. Hamilton The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α J. Immunol. 154 1995 5235 5244
31. N. Custodio, M. Carmo-Fonseca, F. Geraghty, H.S. Pereira, F. Grosveld, and M. Antoniou Inefficient processing impairs release of RNA from the site of transcription EMBO J. 18 1999 2855 2866
32. S.R. Snyder, J.F. Waring, S.Z. Zhu, S. Kaplan, J. Schultz, and G.D. Ginder A3′-transcribed region of the HLA-A2 gene mediates posttranscriptional stimulation by IFNγ J. Immunol. 166 2001 3966 3974
33. J. Frostegard, A.K. Ulfgren, P. Nyberg, U. Hedin, J. Swedenborg, and U. Andersson Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines Atherosclerosis 145 1999 33 43
34. X. Zhou, G. Paulsson, S. Stemme, and G.K. Hansson Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice J. Clin. Invest. 101 1998 1717 1725
35. P. Loetscher, A. Pellegrino, J.H. Gong, I. Mattioli, M. Loetscher, and G. Bardi The ligands of CXC chemokine receptor 3, I-Tac, Mig and IP-10, are natural antagonists for CCR3 J. Biol. Chem. 276 2001 2986 2991
36. A.D. Luster, R.D. Cardiff, J.A. MacLean, K. Crowe, and R.D. Granstein Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine Proc. Assoc. Am. Physicians 110 1998 183 196
37. K.S. Moulton, E. Heller, M.A. Konerding, E. Flynn, W. Palinski, and J. Folkman Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice Circulation 99 1999 1726 1732
38. O.J. de Boer, A.C. van der Wal, P. Teeling, and A.E. Becker Leukocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc. Res. 41 1998 443 449
39. X. Wang, T. Yue, E.H. Ohlsten, C. Sung, and G.Z. Feuerstein Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response J. Biol. Chem. 271 1996 24286 24293
40. S. Manzi, E.N. Meilahn, J.E. Rairie, C.G. Conte, T.A. Medsger Jr., and L. Jansen-McWilliams Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study Am. J. Epidemiol. 145 1997 408 415
41. J.H.S. Kabarowski, K. Zhu, L.Q. Le, O.N. Witte, and Y. Xu Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A Science 293 2001 702 705
42. K. Zhu, L.M. Baundhuin, G. Hong, F.S. Williams, K.L. Cristina, and L. Song Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4 J. Biol. Chem. 276 2001 41325 41334